ESR1 and head and neck cancer: Using data from The Cancer Genome Atlas, we and others have shown that the estrogen receptor alpha (ERα) is overexpressed in HPV+HNC (head and neck cancers including OPCs) and that these elevated levels are associated with an improved disease outcome (18, 20, –, 26).